| GeneID | Gene_Symbol | DisGeNet_diseaseID | Disease_name |  DisGeNet score | DisGeNet_sourceDB |
| 3718 | JAK3 | C0085110 | Severe Combined Immunodeficiency | 0.220994226560514 | BEFREE;GAD;HPO;LHGDN |
| 3718 | JAK3 | C0032285 | Pneumonia | 0.200274726784213 | BEFREE;HPO |
| 3718 | JAK3 | C0349639 | Juvenile Myelomonocytic Leukemia | 0.200274726784213 | BEFREE;CTD_human |
| 3718 | JAK3 | C0011991 | Diarrhea | 0.2 | HPO |
| 3718 | JAK3 | C0021843 | Intestinal Obstruction | 0.2 | HPO |
| 3718 | JAK3 | C0025289 | Meningitis | 0.2 | HPO |
| 3718 | JAK3 | C0149727 | LYMPH NODE ABNORMALITY | 0.2 | HPO |
| 3718 | JAK3 | C0231246 | Failure to gain weight | 0.2 | HPO |
| 3718 | JAK3 | C0581381 | Recurrent upper respiratory tract infection | 0.2 | HPO |
| 3718 | JAK3 | C1328587 | Panhypogammaglobulinemia | 0.2 | HPO |
| 3718 | JAK3 | C1833275 | Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Positive, NK Cell-Negative | 0.2 | ORPHANET |
| 3718 | JAK3 | C1855781 | Lack of delayed skin hypersensitivity reaction | 0.2 | HPO |
| 3718 | JAK3 | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 0.2 | CTD_human |
| 3718 | JAK3 | C2315100 | Pediatric failure to thrive | 0.2 | HPO |
| 3718 | JAK3 | C4020899 | Autosomal recessive predisposition | 0.2 | HPO |
| 3718 | JAK3 | C0018133 | Graft-vs-Host Disease | 0.0802747267842131 | BEFREE;RGD |
| 3718 | JAK3 | C0009375 | Colonic Neoplasms | 0.08 | RGD |
| 3718 | JAK3 | C0011853 | Diabetes Mellitus, Experimental | 0.08 | RGD |
| 3718 | JAK3 | C0014072 | Experimental Autoimmune Encephalomyelitis | 0.08 | RGD |
| 3718 | JAK3 | C0020429 | Hyperalgesia | 0.08 | RGD |
| 3718 | JAK3 | C0993582 | Arthritis, Experimental | 0.08 | RGD |
| 3718 | JAK3 | C1837028 | Severe Combined Immunodeficiency, Autosomal Recessive, T Cell Negative, B Cell Positive, NK Cell Positive | 0.08 | MGD |
| 3718 | JAK3 | C0013080 | Down Syndrome | 0.00874819096286746 | BEFREE;LHGDN |
| 3718 | JAK3 | C0027022 | Myeloproliferative disease | 0.0060152784980537 | BEFREE;LHGDN |
| 3718 | JAK3 | C0206180 | Ki-1+ Anaplastic Large Cell Lymphoma | 0.0060152784980537 | BEFREE;LHGDN |
| 3718 | JAK3 | C0023473 | Myeloid Leukemia, Chronic | 0.004814057046576 | GAD |
| 3718 | JAK3 | C0023462 | Acute Megakaryocytic Leukemias | 0.00410654638587925 | BEFREE;LHGDN |
| 3718 | JAK3 | C0079773 | Lymphoma, T-Cell, Cutaneous | 0.00410654638587925 | BEFREE;LHGDN |
| 3718 | JAK3 | C0021051 | Immunologic Deficiency Syndromes | 0.0029564820917142 | BEFREE;GAD |
| 3718 | JAK3 | C0023493 | Adult T-Cell Lymphoma/Leukemia | 0.0029564820917142 | BEFREE;GAD |
| 3718 | JAK3 | C0024312 | Lymphopenia | 0.0029564820917142 | BEFREE;GAD |
| 3718 | JAK3 | C0025202 | melanoma | 0.00273291246481375 | LHGDN |
| 3718 | JAK3 | C0079744 | Diffuse Large B-Cell Lymphoma | 0.0026817553075011 | BEFREE;GAD |
| 3718 | JAK3 | C0242379 | Malignant neoplasm of lung | 0.0026817553075011 | BEFREE;GAD |
| 3718 | JAK3 | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.0026817553075011 | BEFREE;GAD |
| 3718 | JAK3 | C0005684 | Malignant neoplasm of urinary bladder | 0.002407028523288 | GAD |
| 3718 | JAK3 | C0024117 | Chronic Obstructive Airway Disease | 0.002407028523288 | GAD |
| 3718 | JAK3 | C0024314 | Lymphoproliferative Disorders | 0.002407028523288 | GAD |
| 3718 | JAK3 | C0026764 | Multiple Myeloma | 0.002407028523288 | GAD |
| 3718 | JAK3 | C0027686 | Pathologic Neovascularization | 0.002407028523288 | GAD |
| 3718 | JAK3 | C3463824 | MYELODYSPLASTIC SYNDROME | 0.002407028523288 | GAD |
| 3718 | JAK3 | C1279481 | X-Linked Combined Immunodeficiency Diseases | 0.0019230874894917 | BEFREE |
| 3718 | JAK3 | C0023418 | leukemia | 0.0016483607052786 | BEFREE |
| 3718 | JAK3 | C0023449 | Acute lymphocytic leukemia | 0.0013736339210655 | BEFREE |
| 3718 | JAK3 | C0023467 | Leukemia, Myelocytic, Acute | 0.0010989071368524 | BEFREE |
| 3718 | JAK3 | C0259743 | Autosomal recessive SCID | 0.0010989071368524 | BEFREE |
| 3718 | JAK3 | C0023452 | Leukemia, Lymphocytic, Acute, L1 | 0.0008241803526393 | BEFREE |
| 3718 | JAK3 | C0024299 | Lymphoma | 0.0008241803526393 | BEFREE |
| 3718 | JAK3 | C0678222 | Breast Carcinoma | 0.0008241803526393 | BEFREE |
| 3718 | JAK3 | C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.0008241803526393 | BEFREE |
| 3718 | JAK3 | C0004364 | Autoimmune Diseases | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0009319 | Colitis | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0023470 | Myeloid Leukemia | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0023494 | Leukemia, T-Cell, Chronic | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0027627 | Neoplasm Metastasis | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0079772 | T-Cell Lymphoma | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0376545 | Hematologic Neoplasms | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0596263 | Carcinogenesis | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C1292769 | Precursor B-cell lymphoblastic leukemia | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C2363142 | T-Cell Prolymphocytic Leukemia | 0.0005494535684262 | BEFREE |
| 3718 | JAK3 | C0001815 | Primary Myelofibrosis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0004096 | Asthma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0004135 | Ataxia Telangiectasia | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0004623 | Bacterial Infections | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0006142 | Malignant neoplasm of breast | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0006274 | Bronchiolitis, Viral | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0007102 | Malignant tumor of colon | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0007131 | Non-Small Cell Lung Carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0007222 | Cardiovascular Diseases | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0007847 | Malignant tumor of cervix | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0015230 | Exanthema | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0017661 | IGA Glomerulonephritis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0017665 | Membranous glomerulonephritis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0017668 | Focal glomerulosclerosis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0018939 | Hematological Disease | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0021390 | Inflammatory Bowel Diseases | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0021400 | Influenza | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0023434 | Chronic Lymphocytic Leukemia | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0023492 | Leukemia, T-Cell | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0023903 | Liver neoplasms | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0025286 | Meningioma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0026683 | Mucocele | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0026769 | Multiple Sclerosis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0028754 | Obesity | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0032463 | Polycythemia Vera | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0036920 | Sezary Syndrome | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0085669 | Acute leukemia | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0086438 | Hypogammaglobulinemia | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0151779 | Cutaneous Melanoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0268124 | Adenosine deaminase deficiency | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0268731 | Renal glomerular disease | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0302592 | Cervix carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0333307 | Superficial ulcer | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0334634 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0346109 | Malignant Mesothelioma of Peritoneum | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0346957 | Disseminated Malignant Neoplasm | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0392607 | Severe combined immunodeficiency due to adenosine deaminase deficiency | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0398686 | Primary immune deficiency disorder | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0403416 | Idiopathic crescentic glomerulonephritis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0424295 | Hyperactive behavior | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0522274 | Humoral immune defect | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0524620 | Metabolic Syndrome X | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0598766 | Leukemogenesis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0598798 | Lymphoid neoplasm | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0684249 | Carcinoma of lung | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0699790 | Colon Carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0699791 | Stomach Carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0836924 | Thrombocytosis | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C0848332 | Spots on skin | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C1306460 | Primary malignant neoplasm of lung | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C1332079 | Anaplastic Large Cell Lymphoma, ALK-Positive | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C1562113 | Fleck corneal dystrophy | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C1834582 | MYELOPROLIFERATIVE SYNDROME, TRANSIENT | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C2239176 | Liver carcinoma | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C3887524 | Skin Erosion | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C3887645 | Job Syndrome | 0.0002747267842131 | BEFREE |
| 3718 | JAK3 | C4048328 | cervical cancer | 0.0002747267842131 | BEFREE |